首页> 外文OA文献 >Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma
【2h】

Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma

机译:IA期透明细胞卵巢癌保胎手术后9年对侧卵巢可能发生从头透明细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A patient who underwent fertility-sparing surgery for Stage IA clear cell carcinoma may have developed de novo clear cell carcinoma in the contralateral ovary 9 years later. She underwent fertility-sparing surgery and postoperative adjuvant chemotherapy for right ovarian carcinoma at 33 years of age (when endometriosis was observed in the contralateral ovary). At the age of 41 years, a tumor was discovered in the left ovary. This was diagnosed pathologically as clear cell carcinoma with clear cell adenofibroma, which may have developed de novo. A consensus is currently taking shape that although fertility-sparing surgery is a therapeutic option for patients with Stage IA clear cell carcinoma, long-term outpatient monitoring is advised to watch for its recurrence or de novo development in the contralateral ovary.
机译:曾为IA期透明细胞癌进行保留生育能力的患者的患者可能在9年后的对侧卵巢中发生了新生的透明细胞癌。她在33岁时(当在对侧卵巢中观察到子宫内膜异位时)接受了保留生育能力的手术和术后辅助化疗以治疗右卵巢癌。在41岁的时候,左卵巢发现了一个肿瘤。经病理诊断为透明细胞腺纤维瘤透明细胞癌,可能是新发的。目前的共识正在形成,尽管对于IA期透明细胞癌患者,保留生育能力的手术是一种治疗选择,但建议长期门诊监测以观察其对侧卵巢的复发或从头发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号